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Mr. Nader discussed NABC’s Vision Statement, characterizing it as tremendously
optimistic. He found the theme of that statement — of what “will” happen
in the future — to be troubling in that, in the 1920s, a radical change in
technology, with similarities to biotechnology, was championed by luminaries
such as Thomas Edison and Henry Ford: to replace hydrocarbons with
carbohydrates. Despite broad support, including deans of MIT and Harvard,
for the concept of manufactured products from plants as raw materials rather
than minerals, it did not come to fruition. Why not? Was the science faulty or
the technology inadequate?
In fact, major industries, e.g. petrochemical, paper and auto, resisted the
change to carbohydrates. The petrochemical industry expanded enormously
in size, and products therefrom came to occupy all major market niches.
Carbohydrate-based products could not compete, and the global repercussions
include hazards in the workplace, environmental pollution, and waste-disposal
costs.
How much is learned from history’s lessons? Industrial hemp, for example,
preceded petrochemicals by thousands of years, yet, despite this long lead time,
it fell out of favor in the 1920s along with many other carbohydrate-based
materials. The role of power in deciding directions — corporate power and
the governmental power it reflects — should be probed at conferences such
as this and not avoided as is usual. For example, over the past seven decades,
little of USDA’s research budget has been invested in carbohydrate development,
whereas subsidies for the oil, gas, nuclear power and forest industries have
been enormous. In the 1960s and 1970s, discussions of auto safety, albeit few,
camouflaged the fact that executives in Detroit emphasized style while progress
in engineering stagnated and never surfaced as a topic of debate. And we must
learn history’s lessons in terms of the corporate personality. The Greek sculptor
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and architect Polyclitus (fifth century BC) said, “Character is destiny,” to which
should be added, “but personality is decisive.”
In the early days of this country, corporations were tightly controlled and
were granted sometimes only a 10-year state charter, renewable on the basis
of good conduct. Products were restricted and expected to fulfill “a public
purpose.” Public perception has since become blurred that there are obvious
differences between corporations and human beings. People cannot be
internationally ubiquitous, cannot dodge responsibilities or be temporarily
bankrupt, and cannot pocket generous remunerations while avoiding full
payment of creditors. The many differences between the corporate personality
and the individual will affect whether the priorities of a biobased economy
in the twenty-first century will be driven by corporate for-profit structure, or
by government and university research with open exchange of information.
The corporate science of today contrasts with the traditional modus operandi
chiefly in terms of:
• Proprietary and confidentiality agreements. When industrial priorities
intersect with research at universities and public institutions, free
exchange of scientific information and the peer-review process are
compromised.
• Priorities. In general, corporate priorities differ from those normally
perceived as being in the public interest. Pharmaceutical companies are
marketing drugs for baldness, obesity, and potency, while neglecting
research to tackle infectious diseases of enormous global relevance, such
as malaria, tuberculosis, and AIDS. As reported recently by the New York
Times, these same companies enjoy billion-dollar governmental subsidies.
• Power. Corporations hold political power by which to garner federal tax
credits and subsidies. This power extrapolates to the presence of
genetically engineered foods on supermarket shelves without being so
labeled, whereas many consumers would welcome such information
for reasons of religion, personal preference, or public policy.
So, on the one hand, corporations hold proprietary information, different
priorities, and power, and, on the other, traditional science is dedicated to
the free pursuit of knowledge for its own sake and for the common good.
The playing field is not level, which should form the basis of discussions with
concrete examples, citing Monsanto, ADM, etc.
In the area of bioengineered food, policy-making is fraught with unknowns.
Part of the problem is that the technology has developed ahead of the scientific
understanding that must underpin its regulation. Industry representatives
have failed to address critical aspects of agricultural biotechnology:
• ecology,
• nutrition and disease dynamics, and
• basic molecular genetics.
The consequences of genetically engineering organisms across species
barriers remain poorly understood. Technology outstripping science has led
to trouble in the past; for example, decades of smog plagued Los Angeles before
it was discovered that motor-vehicle exhaust was causal. And nuclear power
plants were built to produce energy inexpensively, yet the resultant radioactive
waste still cannot be stored safely for the long term. The distinctions between
corporate science and its traditional university-based counterpart need
emphasis.
Who will make the key decisions? Will it be a random process influenced by
who has the funding to do the research, who has the political power, or who
makes the discoveries that lead to implementation? Or will our supposedly
democratically representative government have a say? The public has the right
to know, in principle at least, and to participate in the deliberations. We should
ask the question, “What do genetically engineered corn and soybean really
do for the farmer and for the consumer, compared to the costs and the
unknowns?” At a recent meeting between Monsanto representatives and citizen
environmental groups, an Iowa farmer growing 3,000 acres of genetically
engineered corn stated that his crop did not taste or yield better, but he was
able to spend more time with his family because he spent less time weeding.
His response should be measured against the misgivings about such crops and
against the questions raised above regarding inadequate research.
It is important that the question of who decides, tough as it is, should be
answered by the many rather than by the few, with consideration given to the
needs of overworked family farmers, of whom so many are in dire straits even
after nine years of national economic growth. Will family farmers and their
producer cooperatives survive and retain independence, or will they go the
way of chicken farmers who, indentured to Tyson, Perdue, etc., make a profit
of just a nickel per broiler (240,000 per year = $12,000). Some call this poultry
peonage.
If the increasingly integrated technology patterns of multi-national
companies result in further losses of family-farms, then rural America, with
its traditional independence and its cultural and political creativity, will be
sacrificed. Is that an acceptable risk without clear-minded projections and
thorough debate?
In contrast with the statement by English philosopher Alfred North
Whitehead (1861–1947) that science has to keep its options open for revision,
much corporate science fails in this regard because of entrenchment of
investments and technologies. The infernal internal combustion engine is
one such entrenched technology: it has changed little in 110 years with its
high incomes from sales and service and its built-in obsolescence.
Revision options are key, and this leads to a consideration of the NABC
Statement 2000 on Agricultural Biotechnology: Promise, Process, Regulation and
Dialogue, which, in Mr. Nader’s opinion, is so self-assured that it fails to address
adequately what may go wrong. For example, the Statement suggests that “what
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is” should be given more weight than the never-ending and untestable “what
if?”. Would scientists at the Council for Responsible Genetics (more on the
CRG later) concur with the concept that the most important risk from a
product is inherent to that product not to the process by which it is made, i.e.
that identical products, however they are made, pose identical risk? And would
scientists at the CRG concur that the genetic roulette is less predictable in
organismal than in molecular genetic improvement?
There are other issues that should be considered at this and future confer-
ences. When huge sums of money are invested in industrial-scale production
of crops, there are global consequences in terms of land control. Is it possible
that reform acts in the developing world will result in new ownership patterns
with land-control by large corporations? Apparently aware of this point, over
a million farmers in India six years ago protested the restrictions that patenting
of seed by Cargill and other agribusiness companies would impose on them
culturally and economically; that demonstration received no press coverage in
the United States.
With good planning, many exciting opportunities — unrelated to genetic
engineering — would exist for small-holding farmers, such as industrial hemp.
Industrial hemp must become a political issue, and a media issue, to be released
from the medieval yoke enforced by the DEA. It should be held up as an object
lesson on how the most versatile plant on earth, in terms of its multiplicity
of uses, has been suppressed and that suppression ignored. Certainly in
environmental terms, industrial hemp is superior to the alternatives that are
used in its place.
Current emphasis on biotechnology as a means of alleviating hunger denies
the central fact that malnourishment results chiefly from unequal distribution
of food, lack of access, and from poverty. As an analogy, two million people die
yearly from tuberculosis, most of them in the developing world, even though
the cure is available, as are resources for delivery. Power structure is the chief
determinant of whether a technology is delivered.
It should be stressed that many innovations in agricultural biotechnology are
driven by profit rather than by need, e.g. soybean has been genetically modified
to sell more of a particular herbicide. This sequence of events will become more
common as seed patents increasingly affect farm practices.
According to Mr. Nader, the integration of the seed and chemical industries
accelerates per-acre expenditures, which will affect patterns of agricultural
credit. Consolidations into larger, fewer farms will parallel the vertical
integration of biotech companies. The editorial of an agribusiness newsletter
recently stated: “Get real, farmers! We are not far away from having fifty
integrated production units in this country delivering food and fiber.” Con-
solidations in the beef, pork and poultry industries are already occurring; with
only fifty production systems, farmers would be integrated into contract units
with little bargaining power, as has been the misfortune of chicken farmers.
The promise of increased yields from genetically engineered seed is yet to
be realized. Other, traditional, approaches exist to improve crop yields and to
alleviate post-harvest losses from rodents, fungi, etc., that plague developing
countries. It is arrogant to presume that exogenous untested technologies that
have neither cultural nor historical context do not jeopardize long-standing
practices and customs. The spiritual aspect of economic activity in agrarian
societies is often underestimated. For example, in northeast Brazil, the many
available varieties of corn play specific roles in the local diet and in customs
and festivals.
On one hand, deliveries of clean water, immunization against devastating
diseases, extension advice to foster traditional practices, land reform and
agricultural credits remain beyond reach for many, yet biotechnology is viewed
as a cure for what ails the developing world. A Nobel Prize awaits the person
who achieves that integration.
The FDA is about six years behind in its promise to develop standards to
address the possibility that genetically modified foods may contain new
allergens or toxins, and their recent pronouncements do nothing to alleviate
concerns. Likewise, the EPA, rather than imposing regulations, continues to
promise guidelines.
The old “one pest, one chemical” model has been superseded by “one pest,
one gene.” Although the number of genes is almost infinite, very little is known
of their relation to resistance or how they may be exploited to address the
problem of development of resistance by pests.
The USDA spends an inadequate sum on risk assessment, only one to two
million dollars per year of the biotech research budget. This illustrates the
pressures that influence the USDA’s research priorities. Significant federal funds
are spent on biotechnology, and there is need for assessment of accompanying
effects of the Bayh-Dole Act (by which universities are encouraged to
collaborate with commercial concerns to promote patenting and the utilization
of inventions arising from federal funding). Some are of the opinion that
passage of the Bayh-Dole Act into law has poisoned relationships among
university researchers, with its encouragement to draw proprietary distinctions
and to wheel and deal. This raises the question of whether non-profit
institutions can remain sufficiently independent of corporate entanglements
for the benefit of society and for the maintenance of free initiative and scientific
exchange — a topic worthy of inclusion on a future agenda.
In the recently published book Natural Capitalism: Creating the Next
Industrial Revolution, Paul Hawkin, Amory Lovins and L. Hunter Lovins discuss
opportunities to improve resource productivity, to get more from less of a raw
material. This approach is being put into practice by Interface, Atlanta, GA, the
largest manufacturer of carpet tile in the world, which is moving towards zero
pollution; if part of a process or product does not add value, it is eliminated.
Hawkin, a practical businessman, cites many similar examples in his book.
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Also, he cites a professor who has drawn up a cost budget for one pound of
hamburger meat: one hundred pounds of mid-west soil and a thousand gallons
of ice-age water from the aquifer. Other examples in the book include, the
manufacture of a semi-conductor chip produces one hundred thousand times
its own weight in waste; a lap-top computer generates close to four thousand
times its own weight in waste; two quarts of gasoline and a thousand quarts of
water are needed to produce a quart of Florida orange juice; and one ton of
paper requires ninety-eight tons of various inputs. Mr. Hawkin has suggested
the objective of ten-fold increases in productivity and efficiency, with all the
attendant benefits.
The Council for Responsible Genetics, founded in 1983 by scientists at
Harvard and MIT, monitors developments in new technologies as they relate
to human genetics and commercial biotech and the environment. The CRG
encourages informed public debate on the social, ethical, and environmental
issues. Their recently published Genetic Bill of Rights for consumers covers
policy issues, privacy rights, and questions of disclosure; it should be required
reading for all stakeholders.
Mr. Nader emphasized that these comments and observations should not
be viewed as negative on biomaterials, which hold promise for small-holding
farmers, for the environment and for poor people abroad. However, any
technology that is driven by a distorted power system can be misused and
become a monster. It can fail to deliver on its promise, like pharmaceutical
research, and it can help concentrate power, which, in the wrong hands may
be very anti-democratic and invade privacy. It is important to bear in mind
all these aspects, which is why there is need for a more deeply deliberative
democracy with increasingly more citizens engaged in discussions of the
serious problems society faces.
We are entertaining ourselves to death. No longer a weekly Saturday
afternoon outing to the Bijou theatre for twelve- and thirteen-year olds,
entertainment is accessible twenty-four hours a day and is the focus of much
of the media, which no longer deal with sensible issues. This conference should
be on C-Span, and in newspaper headlines instead of the continuous fodder
of Elian Gonzalez, O.J. Simpson, reprobate celebrities, etc. For functional and
normative reasons, there is need to encourage understanding, commitment,
and skepticism in the citizenry. The jurist Learned Hand (1872–1961) said,
“Whatever our constitutions, whatever our laws may be, the only basic hope
for a democratic society lies in the public sentiments of its people, namely its
civic culture.” This holds true for the emergence of biotechnology, which is
likely to be enormously, fundamentally, and irretrievably transforming for the
planet as a whole; we must tread very carefully indeed.
“A free society made up of free people” brings to mind the definition of
freedom expressed by the Roman orator Marcus Cicero (106–43 BC): “Freedom
is participation in power.” Many centuries ago, an anonymous Chinese sage
commented, “To know and not act is not to know.” Inhibition and self-
censorship that are concomitant with excessive concentration of power must
not encumber free sharing of information by those who are informed.
Most of Mr. Nader’s comments were related to food and applications of
biotechnology, rather than to agriculture’s expanding role in the twenty-first
century, the theme of the Keynote Session. However, as noted, he did express
support for the development of biobased industrial products.
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